Engraftment Syndrome after Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Effects on Survival
Open Access
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (7) , 542-550
- https://doi.org/10.1016/j.bbmt.2005.04.009
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Engraftment Syndrome Emerges as the Main Cause of Transplant-Related Mortality in Pediatric Patients Receiving Autologous Peripheral Blood Progenitor Cell TransplantationJournal of Pediatric Hematology/Oncology, 2004
- Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survivalTransplantation and Cellular Therapy, 2001
- An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell doseBone Marrow Transplantation, 2000
- Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administrationBone Marrow Transplantation, 2000
- Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patientsBone Marrow Transplantation, 1997
- Amphotericin B Induces Tumor Necrosis Factor Production by Murine MacrophagesThe Journal of Infectious Diseases, 1989
- Problems on Pennsylvania AvenueNew England Journal of Medicine, 1986
- Acute Pulmonary Decompensation Due to Amphotericin B in the Absence of Granulocyte TransfusionsNew England Journal of Medicine, 1986
- Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte TransfusionsNew England Journal of Medicine, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958